Hyperthermia and Thermosensitive Liposomes for Improved Delivery of Chemotherapeutic Drugs to Solid Tumors
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Lipid-based nanocarriers or liposomes have been proven successful in the delivery of chemotherapeutic agents and are currently applied clinically in the treatment of various types of cancer. Liposomes offer the advantage of a high drug payload, decreased drug toxicity and enhanced drug accumulation at tumor sites. Increased accumulation is due to the relatively leaky tumor vasculature that allows liposome extravasation. Between different types of tumors and even within one tumor, vascular permeability and thus liposome extravasation may differ greatly. Furthermore, upon accumulation of liposomes in the tumor area, drug bioavailability is not guaranteed. At present, these are the major issues for clinically used liposomal drugs.Mild hyperthermia (HT), the heating of tumor tissue to temperatures of up to 43 degrees C, has been developed in the past decades as an established and efficacious treatment modality in combination with chemo- and radiotherapy. HT can be used to further improve liposomal chemotherapy in two ways: HT is known to increase vascular permeability in solid tumors and may therefore increase levels of liposome accumulation, and thermosensitive liposomes have been developed that can be triggered to release their contents upon hyperthermia. By applying these two strategies, drug delivery to tumors can be strongly enhanced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design of Liposomes for Enhanced Local Release of Drugs by Hyperthermia
Yatvin, M. B., Weinstein, J. N., Dennis, W. H., & Blumenthal, R. (1978) · Science · doi:10.1126/science.364652 · Cited by 956
Needham, D., Anyarambhatla, G., Kong, G., & Dewhirst, M. W. (2000) · PubMed · Cited by 746
Dvorak, H. F., Nagy, J. A., Dvorák, J., & Dvořàk, A. M. (1988) · PubMed Central · Cited by 679
Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size.
Kong, G., Braun, R. D., & Dewhirst, M. W. (2000) · PubMed · Cited by 633
Harrington, K. J., Mohammadtaghi, S., Uster, P. S., Glass, D. M., Peters, A. M., Vile, R. G., & Stewart, J. S. W. (2001) · PubMed · Cited by 575
Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature.
Kong, G., Braun, R. D., & Dewhirst, M. W. (2001) · PubMed · Cited by 442
Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors
Laginha, K. M., Verwoert, S., Charrois, G. J. R., & Allen, T. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0343 · Cited by 441
Ponce, A. M., Viglianti, B. L., Yu, D., Yarmolenko, P. S., Michelich, C. R., Woo, J., Bally, M. B., & Dewhirst, M. W. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk005 · Cited by 273
Colombo, R., Da Pozzo, L. F., Salonia, A., Rigatti, P., Leib, Z., Baniel, J., Caldarera, E., & Pavone-Macaluso, M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.089 · Cited by 267
Novel Temperature-Sensitive Liposomes with Prolonged Circulation Time
Lindner, L. H., Eichhorn, M. E., Eibl, H., Teichert, N., Schmitt-Sody, M., Issels, R. D., & Dellian, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0035 · Cited by 258
Self-citationTriggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia
Li, L., ten Hagen, T. L. M., Schipper, D., Wijnberg, T. M., van Rhoon, G. C., Eggermont, A. M. M., Lindner, L. H., & Koning, G. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.006 · Cited by 214
Self-citationSeynhaeve, A. L. B., Hoving, S., Schipper, D., Vermeulen, C. E., aan de Wiel-Ambagtsheer, G., van Tiel, S. T., Eggermont, A. M. M., & ten Hagen, T. L. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1599 · Cited by 173
Self-citationEfficacy and safety of liposomal anthracyclines in Phase I/II clinical trials
Alberts, D. S., Muggia, F. M., Carmichael, J., Winer, E. P., Jahanzeb, M., Venook, A. P., Skubitz, K. M., Rivera, E., Sparano, J. A., DiBella, N. J., et al. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.08.010 · Cited by 139
Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome
Chen, Q., Tong, S., Dewhirst, M. W., & Yuan, F. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1311.3.10 · Cited by 125
Unezaki, S., Maruyama, K., Takahashi, N., Koyama, M., Yuda, T., Suginaka, A., & Iwatsuru, M. (1994) · Pharmaceutical Research · doi:10.1023/a:1018949218380 · Cited by 114
Targeted Multifunctional Lipid-Based Nanocarriers for Image-Guided Drug Delivery
Koning, G. A., & Krijger, G. C. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007781058613 · Cited by 86
Self-citationPeller, M., Schwerdt, A., Hossann, M., Reinl, H. M., Wang, T., Sourbron, S. P., Ogris, M., & Lindner, L. H. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e31818768cd · Cited by 44
Self-citation
Cited by
Advances in Magnetic Nanoparticles for Biomedical Applications
Cardoso, V. F., Francesko, A., Ribeiro, C., Bañobre‐López, M., Martins, P., & Lanceros‐Mendez, S. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700845 · Cited by 723
Thermosensitive liposomes for localized delivery and triggered release of chemotherapy
Ta, T., & Porter, T. M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.036 · Cited by 403
Evolution and clinical translation of drug delivery nanomaterials
Hassan, S., Prakash, G., Bal Ozturk, A., Saghazadeh, S., Farhan Sohail, M., Seo, J., Remzi Dokmeci, M., Zhang, Y. S., & Khademhosseini, A. (2017) · Nano Today · doi:10.1016/j.nantod.2017.06.008 · Cited by 288
Ultrasound and microbubble mediated therapeutic delivery: Underlying mechanisms and future outlook
Chowdhury, S. M., Abou-Elkacem, L., Lee, T., Dahl, J., & Lutz, A. M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.06.008 · Cited by 284
Landon, C. D. (2011) · The Open Nanomedicine Journal · doi:10.2174/1875933501103010038 · Cited by 281
Metadata
- Authors
- Koning, G. A., Eggermont, A. M. M., Lindner, L. H., & ten Hagen, T. L. M.
- Venue
- Pharmaceutical Research
- Published
- 2010-04-28
- Volume
- 27
- Issue
- 8
- Pages
- 1750-1754
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1978521258
- Cited by
- 254
- References
- 17
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.